JKS heads into the final week of September with short interest near a one-month high, options sentiment shifted sharply toward caution, and a stock that has now shed 34% in a single month — all against the backdrop of an October 30 earnings date that last quarter produced a 12.8% one-day drop.
The short positioning picture has evolved since last week's note. After the explosive build around September 9 — when shorts added roughly 600,000 shares in a single session — the position has largely held. Short interest eased fractionally on the week's last session to 7.25% of the free float, but the one-month change is still a 32% increase in borrowed shares. That's a sustained, not opportunistic, rebuild. Borrowing remains cheap at 0.72% annualised, barely above mid-August levels despite the increased demand. Availability is comfortably in the normal range at 130%, meaning the lending pool is not under meaningful stress — plenty of capacity remains for shorts to add further without facing a squeeze in the borrow market.
Options have become the more interesting signal this week. Investors are now significantly more defensive than their recent average. The put/call ratio climbed to 0.56 — nearly two standard deviations above the 20-day mean of 0.43 — a sharp reversal from the low-PCR readings that ran from mid-September through last Thursday. As recently as September 18, the PCR printed at its 52-week low of 0.37, meaning the swing toward puts happened fast and in the final sessions of the week. That kind of late-week rotation toward downside protection, into a stock already down 34% on the month, points to hedging ahead of the October 30 print rather than any fresh conviction on direction.
The Street offers little comfort for bulls. The most recent analyst action came from Roth Capital's Philip Shen, who cut his target to $16 from $25 following the August earnings disaster — itself a 36% reduction. The consensus mean price target of $22.73 implies substantial upside from the current $10.48, but that figure is heavily influenced by the Daiwa upgrade from March (to Buy, target $28.50) and Goldman's persistent Sell rating with a $20 target. Goldman has held that Sell rating through multiple target revisions. The ORTEX short score has been running above 70 for most of the past two weeks — a level that places JKS in roughly the bottom 4th percentile for short positioning across the universe — while EPS momentum ranks are among the weakest available (4th percentile on 30-day, 3rd on 90-day). The price-to-book multiple has compressed to 0.22x, down 28% in the past month alone.
Institutional flows offer a mixed read. BlackRock added 536,000 shares through August, a notable conviction move into the drawdown. Storebrand and UBS Asset Management also built positions meaningfully into mid-year. Against that, the insider ledger runs the other way. Director LI XIANHUA sold 1.28 million shares in May at $25.53 — a $32.7 million disposal — and separately sold 16,000 shares in June at $16.49. The net insider position over the past 90 days is negative 1.3 million shares, worth roughly $33.5 million at transaction prices. The CEO and CFO received share grants in May, classified as awards rather than open-market purchases, so they carry limited conviction signal. The net picture is institutional buyers accumulating while insiders reduce — a tension that has not resolved.
The earnings history makes the October 30 setup the dominant variable from here. The most recent print on August 26 delivered a 12.8% one-day decline and a 19.6% five-day loss. The prior quarter's print produced a 1.8% gain on day one but then a 14.7% loss over five sessions — so the market has punished JKS on both sides of a miss. Peer performance this week underscores the isolation: DQ gained 9.3% and CSIQ was essentially flat, while JKS fell another 2.1%. The closest correlated peer divergence, combined with a short score that has barely moved despite this week's tiny short-covering, frames what to watch next: whether the options caution that emerged in the final days of this week holds or intensifies as October 30 approaches.
See the live data behind this article on ORTEX.
Open JKS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
